Detailed Information

Cited 19 time in webofscience Cited 22 time in scopus
Metadata Downloads

2 '',4 ''-O-Diacetylquercitrin, a Novel Advanced Glycation End-Product Formation and Aldose Reductase Inhibitor from Melastoma sanguineum

Full metadata record
DC Field Value Language
dc.contributor.authorLee, Ik-Soo-
dc.contributor.authorKim, Il Soon-
dc.contributor.authorLee, Yun Mi-
dc.contributor.authorLee, Youngseop-
dc.contributor.authorKim, Joo-Hwan-
dc.contributor.authorKim, Jin Sook-
dc.date.available2020-02-28T23:45:48Z-
dc.date.created2020-02-06-
dc.date.issued2013-06-
dc.identifier.issn0009-2363-
dc.identifier.urihttps://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/14508-
dc.description.abstractA new flavonoid, 2,'' 4 ''-O-diacetylquercitrin (1), along with six known flavonoids (2-7) were isolated from the aerial parts of Melastoma sanguineunz. The structure of the new flavonoid was established by extensive spectroscopic studies and chemical evidence. The inhibitory effects of isolated compounds (1-7) on advanced glycation end-products (AGEs) formation and rat lens aldose reductase (RLAR) in vitro were examined. Of the tested compounds, compound 1 was the strongest inhibitor of AGEs, with an IC50 of 11.46 +/- 0.44 mu m. In the RLAR assay, all tested compounds exhibited greater inhibitory effects on RLAR than that of a positive control, 3,3-tetramethyleneglutaric acid (10(50)=28.8 +/- 1.5 mu m); compound 1 exhibited the strongest RLAR-inhibitory activity, with an IC50 of 0.077 +/- 0.003 mu m.-
dc.language영어-
dc.language.isoen-
dc.publisherPHARMACEUTICAL SOC JAPAN-
dc.relation.isPartOfCHEMICAL & PHARMACEUTICAL BULLETIN-
dc.title2 '',4 ''-O-Diacetylquercitrin, a Novel Advanced Glycation End-Product Formation and Aldose Reductase Inhibitor from Melastoma sanguineum-
dc.typeArticle-
dc.type.rimsART-
dc.description.journalClass1-
dc.identifier.wosid000319787200010-
dc.identifier.doi10.1248/cpb.c12-00877-
dc.identifier.bibliographicCitationCHEMICAL & PHARMACEUTICAL BULLETIN, v.61, no.6, pp.662 - 665-
dc.identifier.scopusid2-s2.0-84878789767-
dc.citation.endPage665-
dc.citation.startPage662-
dc.citation.titleCHEMICAL & PHARMACEUTICAL BULLETIN-
dc.citation.volume61-
dc.citation.number6-
dc.contributor.affiliatedAuthorKim, Joo-Hwan-
dc.type.docTypeArticle-
dc.subject.keywordAuthorMelastonia sanguineum-
dc.subject.keywordAuthorflavonoid-
dc.subject.keywordAuthoradvanced glycation end-product-
dc.subject.keywordAuthorrat lens aldose reductase-
dc.subject.keywordPlusPROTEIN GLYCATION-
dc.subject.keywordPlusSTRUCTURAL REQUIREMENTS-
dc.subject.keywordPlusDIABETIC COMPLICATIONS-
dc.subject.keywordPlusERIGERON-ANNUUS-
dc.subject.keywordPlusFLAVONOIDS-
dc.subject.keywordPlusGLYCOSIDES-
dc.subject.keywordPlusLEAVES-
dc.subject.keywordPlusWALL-
dc.relation.journalResearchAreaPharmacology & Pharmacy-
dc.relation.journalResearchAreaChemistry-
dc.relation.journalWebOfScienceCategoryChemistry, Medicinal-
dc.relation.journalWebOfScienceCategoryChemistry, Multidisciplinary-
dc.relation.journalWebOfScienceCategoryPharmacology & Pharmacy-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
Files in This Item
There are no files associated with this item.
Appears in
Collections
바이오나노대학 > 생명과학과 > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Kim, Joo-Hwan photo

Kim, Joo-Hwan
BioNano Technology (Department of Life Sciences)
Read more

Altmetrics

Total Views & Downloads

BROWSE